Poplar Therapeutics
Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions
$45MSeries A+
Role not disclosedLoading investors…
Activity from announced rounds
Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions
Develops automated flight control systems for aircraft
Pitching ArrowMark Partners? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room